Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion

Bibliographic Details
Main Authors: Philip L. Mar, MD, PharmD, Lorrel E. Brown, MD, Luke Chong, MD, Rakesh Gopinathannair, MD, MA, FHRS
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:HeartRhythm Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221402711930171X
id doaj-4a821d24c21a4d5f97b888fc6b555498
record_format Article
spelling doaj-4a821d24c21a4d5f97b888fc6b5554982021-07-02T11:48:01ZengElsevierHeartRhythm Case Reports2214-02712020-03-0163144147Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusionPhilip L. Mar, MD, PharmD0Lorrel E. Brown, MD1Luke Chong, MD2Rakesh Gopinathannair, MD, MA, FHRS3Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky; Center for Cardiovascular Care, Saint Louis University, St Louis, MissouriDepartment of Medicine, University of Louisville School of Medicine, Louisville, KentuckyCenter for Cardiovascular Care, Saint Louis University, St Louis, MissouriKansas City Heart Rhythm Institute, Kansas City, Kansas; Address reprint requests and correspondence: Dr Rakesh Gopinathannair, Cardiac EP Lab Director, Kansas City Heart Rhythm Institute, 5100 W 110th St, Ste 200, Overland Park, KS 66211.http://www.sciencedirect.com/science/article/pii/S221402711930171XAdverse drug effectAnticoagulationDabigatranNovel oral anticoagulantReversalThromboembolism
collection DOAJ
language English
format Article
sources DOAJ
author Philip L. Mar, MD, PharmD
Lorrel E. Brown, MD
Luke Chong, MD
Rakesh Gopinathannair, MD, MA, FHRS
spellingShingle Philip L. Mar, MD, PharmD
Lorrel E. Brown, MD
Luke Chong, MD
Rakesh Gopinathannair, MD, MA, FHRS
Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
HeartRhythm Case Reports
Adverse drug effect
Anticoagulation
Dabigatran
Novel oral anticoagulant
Reversal
Thromboembolism
author_facet Philip L. Mar, MD, PharmD
Lorrel E. Brown, MD
Luke Chong, MD
Rakesh Gopinathannair, MD, MA, FHRS
author_sort Philip L. Mar, MD, PharmD
title Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
title_short Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
title_full Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
title_fullStr Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
title_full_unstemmed Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
title_sort multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
publisher Elsevier
series HeartRhythm Case Reports
issn 2214-0271
publishDate 2020-03-01
topic Adverse drug effect
Anticoagulation
Dabigatran
Novel oral anticoagulant
Reversal
Thromboembolism
url http://www.sciencedirect.com/science/article/pii/S221402711930171X
work_keys_str_mv AT philiplmarmdpharmd multichamberintracardiacthrombosisduringnoveloralanticoagulationreversalwithactivatedprothrombincomplexconcentrateinfusion
AT lorrelebrownmd multichamberintracardiacthrombosisduringnoveloralanticoagulationreversalwithactivatedprothrombincomplexconcentrateinfusion
AT lukechongmd multichamberintracardiacthrombosisduringnoveloralanticoagulationreversalwithactivatedprothrombincomplexconcentrateinfusion
AT rakeshgopinathannairmdmafhrs multichamberintracardiacthrombosisduringnoveloralanticoagulationreversalwithactivatedprothrombincomplexconcentrateinfusion
_version_ 1721330635092525056